SEARCH

PTAB.US: Decisions of PTAB Patent Trial and Appeal Board Updated Daily.

Tuesday, May 4, 2010

Tuesday May 4, 2010

AFFIRMED-IN-PART

1600 Biotechnology and Organic Chemistry
Ex Parte Ackerman et al 09/791,138 GREEN 103(a) FRANK ROSENBERG EXAMINER NAFF, DAVID M

In general, a limitation is inherent if it is the "‘natural result flowing from’" the explicit disclosure of the prior art. Schering Corp. v. Geneva Pharms. , 339 F.3d 1373, 1379 (Fed. Cir. 2003).

Schering Corp. v. Geneva Pharm. Inc., 339 F.3d 1373, 67 USPQ2d 1664 (Fed. Cir. 2003). . . . . . . . . . . . . . . . . . . . . . . . .2112


Ex Parte Beermann et al 10/497,173 PRATS 112(2)/103(a) BACON & THOMAS, PLLC EXAMINER OLSON, ERIC

"[B]readth is not to be equated with indefiniteness." In re Miller, 441 F.2d 689, 693 (CCPA 1971).

Miller, In re, 441 F.2d 689, 169 USPQ 597 (CCPA 1971) . . . . . . . . . . . . . . . . . . . . 2173.04

1700 Chemical & Materials Engineering
Ex Parte Eckels et al 11/158,480 OWENS 102(e)/103(a) LAWRENCE LIVERMORE NATIONAL LABORATORY EXAMINER SIEFKE, SAMUEL P

However, the use of different terms in a claim indicates, absent evidence to the contrary, that different elements are required. Cf. CAE Screen Plates, Inc. v. Heinrich Fiedler GMBH & Co. KG, 224 F.3d 1308, 1317 (Fed. Cir. 2000) (“In the absence of any evidence to the contrary, we must presume that the use of these different terms in the claims connotes different meanings.”) (citation omitted).

No comments :